(Q33194696)

23 July 2017

Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries (English)

1 reference

23 July 2017

Policymakers’ views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries (English)

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00533-4

29 March 2024

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604579

29 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00533-4

29 March 2024

3

John D Clemens

1 reference

23 July 2017

2

Jacqueline Deen

1 reference

23 July 2017

Denise DeRoeck

1

1 reference

23 July 2017

Jacqueline Deen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604579

29 March 2024

John D. Clemens

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604579

29 March 2024

language of work or name

English

0 references

publication date

1 December 2003

1 reference

23 July 2017

8 December 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14604579

full work available at URL

29 March 2024

https://api.elsevier.com/content/article/PII:S0264410X03005334?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00533-4

https://api.elsevier.com/content/article/PII:S0264410X03005334?httpAccept=text/plain

29 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00533-4

29 March 2024

1 reference

23 July 2017

22

1 reference

23 July 2017

1

1 reference

23 July 2017

121-129

1 reference

Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Dengue and other emerging flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Dengue and dengue hemorrhagic fever in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Dengue: emergence as a global public health problem and prospects for control

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Dengue and dengue haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Pathogenesis of dengue: challenges to molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

The future of dengue vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Live attenuated tetravalent dengue vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Development of new vaccines against dengue fever and Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Dengue vaccine design: issues and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900533-4

7 January 2021

Vaccination against typhoid fever: present status

27

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00533-4

Global burden of Shigella infections: implications for vaccine development and implementation of control strategies

29 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/S0264-410X(03)00533-4

29 March 2024

Identifiers

1 reference

23 July 2017

1 reference